Serveur d'exploration Chloroquine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Antimalarials: unapproved uses or indications

Identifieur interne : 002571 ( Main/Exploration ); précédent : 002570; suivant : 002572

Antimalarials: unapproved uses or indications

Auteurs : Ronni Wolf [Israël] ; Danny Wolf [Israël] ; Vincenzo Ruocco [Italie]

Source :

RBID : ISTEX:FC4F9EDF7F761B7D5166AD02E9022AF8A3618BD9

English descriptors


Url:
DOI: 10.1016/S0738-081X(99)00092-9


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Antimalarials: unapproved uses or indications</title>
<author>
<name sortKey="Wolf, Ronni" sort="Wolf, Ronni" uniqKey="Wolf R" first="Ronni" last="Wolf">Ronni Wolf</name>
</author>
<author>
<name sortKey="Wolf, Danny" sort="Wolf, Danny" uniqKey="Wolf D" first="Danny" last="Wolf">Danny Wolf</name>
</author>
<author>
<name sortKey="Ruocco, Vincenzo" sort="Ruocco, Vincenzo" uniqKey="Ruocco V" first="Vincenzo" last="Ruocco">Vincenzo Ruocco</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:FC4F9EDF7F761B7D5166AD02E9022AF8A3618BD9</idno>
<date when="2000" year="2000">2000</date>
<idno type="doi">10.1016/S0738-081X(99)00092-9</idno>
<idno type="url">https://api.istex.fr/ark:/67375/6H6-76P0K43Z-1/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000021</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000021</idno>
<idno type="wicri:Area/Istex/Curation">000021</idno>
<idno type="wicri:Area/Istex/Checkpoint">001389</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001389</idno>
<idno type="wicri:doubleKey">0738-081X:2000:Wolf R:antimalarials:unapproved:uses</idno>
<idno type="wicri:Area/Main/Merge">002599</idno>
<idno type="wicri:Area/Main/Curation">002571</idno>
<idno type="wicri:Area/Main/Exploration">002571</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Antimalarials: unapproved uses or indications</title>
<author>
<name sortKey="Wolf, Ronni" sort="Wolf, Ronni" uniqKey="Wolf R" first="Ronni" last="Wolf">Ronni Wolf</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Israël</country>
<wicri:regionArea>the Department of Dermatology, Tel-Aviv Sourasky Medical Center, Ichilov Hospital, and the Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv</wicri:regionArea>
<wicri:noRegion>Tel-Aviv</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<country xml:lang="fr">Israël</country>
<wicri:regionArea>Address correspondence to Ronni Wolf, MD, Dept. of Dermatology, Tel-Aviv Sourasky Medical Center, 6 Weizman St., Tel-Aviv 64239</wicri:regionArea>
<wicri:noRegion>Tel-Aviv 64239</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Wolf, Danny" sort="Wolf, Danny" uniqKey="Wolf D" first="Danny" last="Wolf">Danny Wolf</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Israël</country>
<wicri:regionArea>the Pediatric Outpatient Clinic, Hasharon Region, Kupat Holim</wicri:regionArea>
<wicri:noRegion>Kupat Holim</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Ruocco, Vincenzo" sort="Ruocco, Vincenzo" uniqKey="Ruocco V" first="Vincenzo" last="Ruocco">Vincenzo Ruocco</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Italie</country>
<wicri:regionArea>the Department of Dermatology, University of Naples II, School of Medicine and Surgery, Naples</wicri:regionArea>
<wicri:noRegion>Naples</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Clinics in Dermatology</title>
<title level="j" type="abbrev">CID</title>
<idno type="ISSN">0738-081X</idno>
<imprint>
<publisher>ELSEVIER</publisher>
<date type="published" when="2000">2000</date>
<biblScope unit="volume">18</biblScope>
<biblScope unit="issue">1</biblScope>
<biblScope unit="page" from="17">17</biblScope>
<biblScope unit="page" to="35">35</biblScope>
</imprint>
<idno type="ISSN">0738-081X</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0738-081X</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="Teeft" xml:lang="en">
<term>Acad</term>
<term>Acad dermatol</term>
<term>Acta</term>
<term>Acta derm venereol</term>
<term>Actinic</term>
<term>Actinic lichen planus</term>
<term>Actinic reticuloid</term>
<term>Agents actions</term>
<term>Annulare</term>
<term>Antimalarial</term>
<term>Antimalarial agent</term>
<term>Antimalarial compounds</term>
<term>Antimalarial drugs</term>
<term>Apoptosis</term>
<term>Arch dermatol</term>
<term>Arthritis</term>
<term>Arthritis rheum</term>
<term>Atabrine</term>
<term>Atopic dermatitis</term>
<term>Beneficial effects</term>
<term>Biochem</term>
<term>Biol</term>
<term>British tuberculosis association</term>
<term>Bullosa</term>
<term>Cell biol</term>
<term>Cell proliferation</term>
<term>Childhood dermatomyositis</term>
<term>Chloroquine</term>
<term>Chloroquine binding</term>
<term>Chloroquine phosphate</term>
<term>Chloroquine therapy</term>
<term>Chloroquine treatment</term>
<term>Chronic actinic dermatitis</term>
<term>Chronic erythema nodosum</term>
<term>Cinchona</term>
<term>Clin</term>
<term>Clinic</term>
<term>Corticosteroid</term>
<term>Cutanea</term>
<term>Cutaneous</term>
<term>Cutaneous lesions</term>
<term>Cutaneous sarcoidosis</term>
<term>Derm</term>
<term>Dermatitis</term>
<term>Dermatol</term>
<term>Dermatology</term>
<term>Dermatomyositis</term>
<term>Dos</term>
<term>Effective therapy</term>
<term>Epidermolysis</term>
<term>Epidermolysis bullosa</term>
<term>Epidermolysis bullosa hereditaria</term>
<term>Eruption</term>
<term>Erythema</term>
<term>Erythema nodosum</term>
<term>Erythematosus</term>
<term>Generalized granuloma annulare</term>
<term>Granuloma</term>
<term>Histamine</term>
<term>Histocompatibility</term>
<term>Hydroxychloroquine</term>
<term>Hydroxychloroquine treatment</term>
<term>Inhibitor</term>
<term>Lesion</term>
<term>Lichen</term>
<term>Lichen planus</term>
<term>Lichen planus actinicus</term>
<term>Lichen sclerosus</term>
<term>Lupus</term>
<term>Lupus erythematosus</term>
<term>Lysosomotropic amines</term>
<term>Macrophage</term>
<term>Mcchesney</term>
<term>Melanin</term>
<term>Muscle involvement</term>
<term>Muscle weakness</term>
<term>Nitric</term>
<term>Nitric oxide</term>
<term>Nodosum</term>
<term>Oral lichen planus</term>
<term>Oral pathol</term>
<term>Oral surg</term>
<term>Panniculitis</term>
<term>Pharmacol</term>
<term>Phospholipase</term>
<term>Planus</term>
<term>Polymorphous</term>
<term>Polymorphous light eruption</term>
<term>Porphyria</term>
<term>Porphyria cutanea tarda</term>
<term>Primary syndrome</term>
<term>Proc natl acad</term>
<term>Protective effect</term>
<term>Pseudopelade</term>
<term>Psoriasis</term>
<term>Psoriatic</term>
<term>Psoriatic arthritis</term>
<term>Pulmonary sarcoidosis</term>
<term>Quinacrine</term>
<term>Quinacrine hydrochloride</term>
<term>Quinine</term>
<term>Rash</term>
<term>Remission</term>
<term>Rheum</term>
<term>Rheumatoid</term>
<term>Rheumatoid arthritis</term>
<term>Rheumatol</term>
<term>Sarcoidosis</term>
<term>Significant decrease</term>
<term>Skin lesions</term>
<term>Solar urticaria</term>
<term>Spectral shift</term>
<term>Steroid</term>
<term>Stockh</term>
<term>Stomatitis</term>
<term>Syndrome</term>
<term>Synthetic models</term>
<term>Systemic</term>
<term>Systemic corticosteroids</term>
<term>Systemic lupus erythematosus</term>
<term>Systemic steroids</term>
<term>Tarda</term>
<term>Therapy</term>
<term>Tissue distribution</term>
<term>Transglutaminase</term>
<term>Transglutaminase activity</term>
<term>Venereol</term>
<term>Vesicle</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
</TEI>
<affiliations>
<list>
<country>
<li>Israël</li>
<li>Italie</li>
</country>
</list>
<tree>
<country name="Israël">
<noRegion>
<name sortKey="Wolf, Ronni" sort="Wolf, Ronni" uniqKey="Wolf R" first="Ronni" last="Wolf">Ronni Wolf</name>
</noRegion>
<name sortKey="Wolf, Danny" sort="Wolf, Danny" uniqKey="Wolf D" first="Danny" last="Wolf">Danny Wolf</name>
<name sortKey="Wolf, Ronni" sort="Wolf, Ronni" uniqKey="Wolf R" first="Ronni" last="Wolf">Ronni Wolf</name>
</country>
<country name="Italie">
<noRegion>
<name sortKey="Ruocco, Vincenzo" sort="Ruocco, Vincenzo" uniqKey="Ruocco V" first="Vincenzo" last="Ruocco">Vincenzo Ruocco</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002571 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002571 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:FC4F9EDF7F761B7D5166AD02E9022AF8A3618BD9
   |texte=   Antimalarials: unapproved uses or indications
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021